FDA STATE_REFERRAL_LETTER - Custom Compounding Center - May 29, 2019

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Record Details

This STATE REFERRAL LETTER record concerns Custom Compounding Center, with an inspection on May 29, 2019, issued by the Office of Pharmaceutical Quality, covering drugs.

Company: Custom Compounding Center
Inspection Date: May 29, 2019
Product Type: Drugs
Office: Office of Pharmaceutical Quality
People: Thao Ta (Compliance Officer)
Mark Shinabery
John W. Diehl (John W. Diehl, M.S.Program Division)
John Clay Kirtley (Executive Director)
William S. Boivin (Retired at FDA)

Open in Dashboard

ID · 390fa9da-062b-4bec-9b1f-2ad6bcc798ae

Violation Codes3

FD&C Act 503A21 CFR 20.64(d)(3)21 CFR 20.88

Full citation text and observation details available on the Dashboard.